Advertisement

Topics

Company Spotlight: Spark Therapeutics

23:32 EDT 29 Jul 2017 | RTTNews

Shares of Spark Therapeutics Inc. (ONCE) have gained nearly 43% year-to-date compared to 21% rise in the iShares Nasdaq Biotechnology Index (ETF) during the same period.

Original Article: Company Spotlight: Spark Therapeutics

NEXT ARTICLE

More From BioPortfolio on "Company Spotlight: Spark Therapeutics"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...